systematic_review
    2013
    High Quality

    Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review

    Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Segal JB

    Published in JAMA

    Key Findings

    Moderate-strength evidence that sublingual immunotherapy reduces rhinitis and rhinoconjunctivitis symptoms and medication use.

    Conclusions

    Sublingual immunotherapy is an effective disease-modifying option for environmental allergies.

    Limitations

    Heterogeneous allergens and dosing schedules.

    Outcomes Measured

    Allergy Relief

    Moderate-strength evidence supports sublingual immunotherapy for improving allergic rhinitis symptoms.

    Related Health Concerns

    Environmental Allergies
    Asthma

    Study Details

    Year:2013
    Quality Score:9/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.